Patent · US Expired

Fibrinogen binding protein originating from coagulase-negative staphylococcus

US6733758B1 · kind B1 · utility

8Cited by

3References

4Claims

0Family size

Inventors

Bengt Guss · Uppsala, SE
Martin Nilsson · Uppsala, SE
Lars Frykberg · Storvreta, SE
Jan-Ingmar Flock · Bromma, SE
Martin Lindberg · Uppsala, SE

Key dates

Filing date	Apr 1, 1999
Grant date	May 11, 2004
Priority date	—
Expiry date	Apr 1, 2019

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S530/825
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A new fibrinogen binding protein or polypeptide originating from coagulase negative staphylococci, biotechnological methods for producing the protein or polypeptide having fibrinogen binding activity and a recombinant DNA molecule coding for the protein (or fragments thereof), and micro-organisms (including viruses) containing this recombinant DNA molecule. The present invention further comprises the therapeutic and diagnostic use of the protein and/or DNA, e.g., a diagnostic kit for determining the presence and/or type of coagulase negative staphylococci and a vaccine composition, comprising the protein or DNA.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.